|

TRX319 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Tr1X, Inc.1

Indications

  • Secondary Progressive Multiple Sclerosis (SPMS)1
  • Multiple Sclerosis (MS) Secondary Progressive1
  • Multiple Sclerosis (MS) Primary Progressive1
  • Primary Progressive Multiple Sclerosis1
  • Multiple Sclerosis1

Kansas City, Kansas1 trial

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

University of Kansas Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.